Update on the Biomarker Core of ADNI subjects

Fri, May 21, 2010

Biomarker Core, Publications

“Here, we review progress by the Penn Biomarker Core in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) toward developing a pathological cerebrospinal fluid (CSF) and plasma biomarker signature for mild Alzheimer’s disease (AD) as well as a biomarker profile that predicts conversion of mild cognitive impairment (MCI) and/or normal control subjects to AD.”

Authors: Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter WZ, Weiner MW, Jack CR Jr, Jagust W, Toga AW, Lee VM, Shaw LM; Alzheimer’s Disease Neuroimaging Initiative.

Alzheimers Dement. 2010 May;6(3):230-8. Review.

Read this article in Pubmed.

More Biomarker Core News

This post was written by: - who has written 40 posts on ADNI.


Comments are closed.

Search ADNI News:

Annual Archives